GSK Leaving Pennsylvania Emergen-C Plant, Adding Voltaren To US OTC Line

 
• By Malcolm Spicer
  
GSK Carlisle
GSK is phasing out production at its Carlisle, PA, production facility by mid-2021 and will full exit the site by the end of that year.

More from Strategy

More from Business